Game-changing equine barrier cream now available
Zarasyl offers equestrians and veterinarians a steroid- and antibiotic-free option for horse skin and wound treatment.
Overuse of antibiotic ointments in barns is contributing to the development of serious diseases (“superbugs”) like Clostridium difficile that wreak havoc on the equine gastrointestinal system and kidneys. Recently launched Zarasyl was designed to offer equestrians and veterinarians an antibiotic- and steroid-free solution for equine wound and skin care.
Inappropriate use of antibiotics is commonly known to cause antibiotic resistance. The problem? According to this company release, few equestrians are aware of the role antibiotic ointments play in creating resistant bacteria and routinely turn to these creams and ointments to treat even the most minor wounds.
Before the development of Zarasyl, equestrians resorted to powders and sprays that severely dried out horse skin or antibiotic ointments that predispose the horse to antibiotic-resistant diseases in the future. Over a decade of research has gone into the patented science behind Zarasyl. The silicate technology featured in this product was initially used to treat human skin issues, but scientists observed benefits for equine skin concerns.
Zaraysl helps manage skin infections such as pastern dermatitis, lacerations, and other similar injuries by moisturizing the skin to support wound healing. It also contains proprietary amorphous silica with a molecular structure, which offers a sustained release of orthosilicic acid (a bioavailable form of silicon associated with healthy connective tissue growth) to the skin.
Tony Kimmons, DVM, owner of Franklin Equine Services, expressed his sentiments about the new innovative product.
“I’ve had several cases with deep penetrating wounds with extensive skin loss that responded extremely well to Zarasyl,” he said, in the release.
To learn more about this new product, go here.